Francis Thien

ORCID: 0000-0003-0925-6566
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Asthma and respiratory diseases
  • Allergic Rhinitis and Sensitization
  • Respiratory and Cough-Related Research
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Inhalation and Respiratory Drug Delivery
  • Food Allergy and Anaphylaxis Research
  • Indoor Air Quality and Microbial Exposure
  • Climate Change and Health Impacts
  • Dermatology and Skin Diseases
  • Eosinophilic Esophagitis
  • Pediatric health and respiratory diseases
  • IL-33, ST2, and ILC Pathways
  • Contact Dermatitis and Allergies
  • Eosinophilic Disorders and Syndromes
  • Atomic and Subatomic Physics Research
  • Olfactory and Sensory Function Studies
  • Noise Effects and Management
  • Fatty Acid Research and Health
  • Air Quality and Health Impacts
  • Drug-Induced Adverse Reactions
  • Occupational exposure and asthma
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Respiratory Support and Mechanisms
  • Medical Imaging and Pathology Studies
  • Lichen and fungal ecology

Box Hill Hospital
2013-2025

Eastern Health
2016-2025

Monash University
2016-2025

Isabela State University
2023

The Alfred Hospital
2001-2020

The University of Melbourne
2001-2020

National Health and Medical Research Council
2020

Australian Regenerative Medicine Institute
2020

Favaloro Foundation
2020

University of South Florida
2020

William W. Busse Eugene R. Bleecker J Mark FitzGerald Gary T. Ferguson Peter Barker and 95 more Stephanie Sproule Richard F. Olsson Ubaldo J. Martin Mitchell Goldman Anahí Yañez Marcelo Fernández Alberto Tolcachier Juan Belloni Jorge Taborda Maria De Salvo Jorge Máspero Carlos Victorio Miguel Chirino Navarta Monica Grilli Pablo Alejandro Rodríguez María Otaola Victor Hugo Cambursano Patricia Malamud Ana Stok German Arce Osiris Roza Fernando Scherbovsky Pedro Carlos Elias Maria Salazan Saez Matthew Peters Michael Phillips John W. Upham Peter G. Gibson Francis Thien John Aubrey Douglass Paul Thomas Philip G. Bardin Dimitar Sajkov Mark Hew David Langton Andreia Luisa Francisco Pez Carlos Cézar Fritscher Jorge Lima Hetzel Waldo Mattos Rafaël Stelmach Martti Antila Ana Luísa Godoy Fernandes Hristo Metev Yavor Ivanov Aneliya Bogdanova Ana Dancheva Markova M Peneva Rumyana Veselinova Tatyana Petkova Vanushka Petrova E Shopova Yuliya Ivanova Rumyana Yotsova Ginka Kirkova Galina Petrova Svetoslav Dachev Kostadinka Sotirova Mariyana Stoyanova Oleg Yakov Vanya Ilieva-Fartunova Catherine Lemière Michel Laviolette William H. Yang J Mark FitzGerald Bonavuth Pek William Patrick Killorn Claude Poirier Guy Chouinard Lyle Melenka Richard Leigh Parameswaran Nair Delbert Dorscheid James G. Martin Juana Pavie Andres Rosenblut Claudia Cartagena Carlos Quilodran Silvia Muñoz Ivana Malkusova J. Veverka Stanislav Holub Jaroslav Mareš Radovan Kozel Daniela Kopecka Vladimir Zindr Pavel Cerva Pascal Chanez Arnaud Bourdin Gilles Devouassoux Camille Taillé Frédéric de Blay François Goupil Christophe Leroyer Delphine Gourcerol T. Didi

10.1016/s2213-2600(18)30406-5 article EN The Lancet Respiratory Medicine 2018-11-08

BackgroundA multidisciplinary collaboration investigated the world's largest, most catastrophic epidemic thunderstorm asthma event that took place in Melbourne, Australia, on Nov 21, 2016, to inform mechanisms and preventive strategies.MethodsMeteorological airborne pollen data, satellite-derived vegetation index, ambulance callouts, emergency department presentations, data hospital admissions for as well leading up following were collected between March 31, 2017, analysed. We contacted...

10.1016/s2542-5196(18)30120-7 article EN cc-by-nc-nd The Lancet Planetary Health 2018-06-01
Toby M. Maher Paul Ford Kevin M. Brown Ulrich Costabel Vincent Cottin and 95 more Sonye K. Danoff Irene Groenveld Eric Helmer Gisli Jenkins Julie Milner Geert Molenberghs Björn Penninckx Matthew J. Randall Bernt van den Blink Ann Fieuw Charlotte Vandenrijn Sanda Rocak Ineke Seghers Lixin Shao Amit Taneja Garrit Jentsch Timothy R. Watkins Wim Wuyts Michael Kreuter Nadia Verbruggen Niyati Prasad Marlies Wijsenbeek Daniel C. Chambers Michael Chia Tamera J. Corte Ian Glaspole Nicole Goh Mark Holmes M.A. Malouf Francis Thien Elizabeth Veitch Benjamin Bondue Caroline Dahlqvist Antoine Froidure Hans Slabbynck Wim Wuyts Claudia Cartagena Salinas Rosa Feijoó Seoane Victor D. Martínez Roxana Maturana Juana Pavie Gallegos Andrés Rosenblüt Rafael Silva Alvaro Undurraga Pereira Martina Doubková Norbert Pauk Martina Plačková Martina Šterclová Elisabeth Bendstrup Saher Burhan Shaker Ingrid Louise Titlestad Stephan Budweiser Christian Grohé Dirk Koschel Michael Kreuter Antje Prasse Michael Weber Hubert Wirtz Katerina M. Antoniou Zoe Daniil Mina Gaga Despoina Papakosta Shinyu Izumi Masaki Okamoto Alfredo Guerreros Benavides Carlos Barrera Alejandro Manuel Peña Villalobos Aranzazu Campo Ezquibela José Manuel Cifrián Estrella Fernández Fabrellas Virginia Leiro María Molina‐Molina Asunción Nieto Barbero Jacobo Sellarés Claudia Valenzuela Shih-Lung Cheng Ping‐Hung Kuo Kang‐Yun Lee Chau‐Chyun Sheu Hakan Günen Nesrin Moğulkoç Sibel Atış Naycı Huzaifa Adamali Stephen Bianchi Nazia Chaudhuri Michael Gibbons Simon P. Hart Philip L. Molyneaux Helen Parfrey Gauri Saini Lisa Spencer Sarah Wiscombe Danielle Antin‐Ozerkis Rebecca Bascom John A. Belperio

There is a major need for effective, well-tolerated treatments idiopathic pulmonary fibrosis (IPF).To assess the efficacy and safety of autotaxin inhibitor ziritaxestat in patients with IPF.The 2 identically designed, phase 3, randomized clinical trials, ISABELA 1 2, were conducted Africa, Asia-Pacific region, Europe, Latin America, Middle East, North America (26 countries). A total 1306 IPF (525 at 106 sites 781 121 2). Enrollment began November 2018 both trials follow-up was completed...

10.1001/jama.2023.5355 article EN JAMA 2023-05-09

Global warming and climate change have increased the pollen burden frequency intensity of wildfires, sand dust storms, thunderstorms, heatwaves—with concomitant increases in air pollution, heat stress, flooding. These environmental stressors alter human exposome trigger complex immune responses. In parallel, pollutants, allergens, other factors increase risks skin mucosal barrier disruption microbial dysbiosis, while a loss biodiversity reduced exposure to diversity impairs tolerogenic...

10.3389/fsci.2024.1279192 article EN cc-by Frontiers in Science 2024-04-04
Ganesh Raghu Luca Richeldi Evans R. Fernández Pérez María Cristina De Salvo Rafael S. Silva and 95 more Jin Woo Song Takashi Ogura Zuo Jun Xu Elizabeth A. Belloli Xueping Zhang Lorilyn L. Seid Lona Poole Simon Bowler Tamera J. Corte Mark Holmes Francis Thien John Wheatley Choi Sun-Mi Man-Pyo Chung Sung-Hwan Jeong Yonghyun Kim Eunjoo Lee Hyun-Kyung Lee Choon‐Sik Park Jong Sun Park Joo Hun Park David Lam Ming-Cheng Chan Kang‐Yun Lee Jie Cao Xinguang Chen Rongchang Chen Huaping Dai Xiuhua Fu Zongan Liang Qun Luo Guochao Shi Zhaohui Tong Limin Wang Shuanying Yang Hongtao Yu Huilan Zhang Jianchu Zhang Hui Zhao Wei Wang Ying Meng Hong Peng Murali Ramaswamy Michael R. Hamblin John E. Fitzgerald Nishant Gupta Jane E. Dematte Srihari Veeraraghavan Thomas O’Brien Tracy Luckhardt Lisa Lancaster M. Kokoszynska Neil Ettinger Thomas D. Kaelin Ather Siddiqi Bridget F. Collins Mary Beth Scholand Danielle Antin‐Ozerkis Kim Hyun Christopher Harden Frank Averill Jorge M. Mallea Rebecca Bascom Vandana Seeram Amy Hajari Case E. James Britt Barry S. Shea Gerard J. Criner Mark H. Gotfried Yolanda Mageto Sherif El Bayadi Cristina Reichner Joshua J. Mooney David Hotchkin Rodeo Abrencillo R. Boente Joyce Lee Alan Betensley Niranjan Jeganathan Rajat Walia Timothy Albertson Iván O. Rosas Dileep Puppala Ladly Abraham Richard I. Enelow Nitin Bhatt Debabratra Bandyopadhyay Pedro Carlos Elias Miguel Bergna Gabriel Ricardo Garcia G. De Stefano Luis Arturo Wehbe Alejandro Chirino Ramón Luévanos Rojas María Otaola

Current treatments for idiopathic pulmonary fibrosis slow the rate of lung function decline, but may be associated with adverse events that affect medication adherence. In phase 2 trials, pamrevlumab (a fully human monoclonal antibody binds to and inhibits connective tissue growth factor activity) attenuated progression without substantial events.

10.1001/jama.2024.8693 article EN JAMA 2024-05-19

ABSTRACT Background and objective A new taxonomic management approach, termed treatable traits, has been proposed for airway diseases including severe asthma. This study examined whether traits could be identified using registry data particular were associated with future exacerbation risk. Methods The Australasian Severe Asthma Web‐Based Database (SAWD) enrolled 434 participants asthma a comparison group of 102 non‐severe Published mapped to fields their prevalence was described....

10.1111/resp.13389 article EN Respirology 2018-09-19

Summary Background The use of allergy tests to guide dietary treatment for eosinophilic oesophagitis (EoE) is controversial and data are limited. Aeroallergen sensitisation patterns food triggers have been defined in Northern Hemisphere cohorts only. Aims To determine if that routinely available can predict adult patients with EoE. define the aeroallergen a novel Southern (Australian) cohort patients. Methods Consecutive EoE who elected undergo therapy were prospectively assessed,...

10.1111/apt.13676 article EN Alimentary Pharmacology & Therapeutics 2016-06-01

<h3>BACKGROUND</h3> There is an increase in vascularity the asthmatic airway. Although inhaled corticosteroids (ICS) are effective anti-inflammatory treatment asthma, there few data on any effects structural changes. <h3>METHODS</h3> Endobronchial biopsy specimens from seven subjects not receiving ICS and 15 200–1500 μg/day beclomethasone dipropionate (BDP) were immunohistochemically stained with anti-collagen type IV antibody to outline endothelial basement membrane of vessels. These...

10.1136/thx.54.4.289 article EN Thorax 1999-04-01

The addition of long-acting β2 agonists to inhaled corticosteroid (ICS) therapy in symptomatic patients with asthma improves clinical status more than increasing the dose ICS. It has been suggested that these benefits could be at cost an increase airway inflammation, but few histopathological studies have performed relevant group. In a double-blind, parallel-group, placebo-controlled study, we randomly assigned 50 who were receiving ICS (range, 100 –500 μ g/d) 12 wk supplementary treatment...

10.1164/ajrccm.160.5.9811052 article EN American Journal of Respiratory and Critical Care Medicine 1999-11-01

There are few data regarding the potential effects of antiasthma treatment on indices airway remodeling, such as increased subepithelial vascularity in patients with asthma. We studied 45 symptomatic subjects asthma who were receiving low dose inhaled corticosteroids (ICS) (range 200-500 microg twice a day) and 28 normal without control population. Subjects underwent bronchoscopy biopsy then randomized to receive supplementary salmeterol 50 day, fluticasone propionate 100 or placebo for 3 mo...

10.1164/ajrccm.164.1.2006003 article EN American Journal of Respiratory and Critical Care Medicine 2001-07-01

Consensus recommendations for managing chronic suppurative lung disease (CSLD) and bronchiectasis, based on systematic reviews, were developed Australian New Zealand children adults during a multidisciplinary workshop. The diagnosis of bronchiectasis requires high-resolution computed tomography scan the chest. People with symptoms but non-diagnostic scans, have CSLD, which may progress to radiological bronchiectasis. CSLD/bronchiectasis is suspected when wet cough persists beyond 8 weeks....

10.5694/j.1326-5377.2010.tb03949.x article EN The Medical Journal of Australia 2010-09-01

Severe asthma is a high impact disease. Omalizumab targets the allergic inflammatory pathway; however, effectiveness data in population with significant comorbidities are limited.To describe severe asthma, omalizumab treatment outcomes and predictors of response among Australian Xolair Registry participants.A web-based post-marketing surveillance registry was established to characterise use, adverse effects (Xolair) for asthma.Participants (n = 192) (mean age 51 years, 118 female) from 21...

10.1111/imj.13166 article EN Internal Medicine Journal 2016-06-28

Summary Background Elimination diets and high‐dose proton pump inhibitors ( PPI ) are advocated as first‐line treatments in patients with eosinophilic oesophagitis (EoE). Aim To record the treatment outcome for EoE prospectively managed according to a clinical algorithm. Methods Patients oesophageal eosinophilia commenced esomeprazole 40 mg twice daily 8 weeks. Those histological remission were re‐classified ‐responsive eosinophilia. Nonresponders offered 6‐food elimination diet , or topical...

10.1111/apt.13576 article EN Alimentary Pharmacology & Therapeutics 2016-03-04

Summary Background Severe asthma affects quality of life; however, its impact on workplace productivity is poorly understood. Objective To compare productivity—absenteeism and presenteeism—and impairment in daily activities severe non‐severe over time identify characteristics associated with presenteeism asthma. Methods The Asthma Web‐based Database an ongoing observational registry from Australia, New Zealand Singapore. At April 2017, 434 patients 102 were enrolled (18‐88 years; 59%...

10.1111/cea.13153 article EN Clinical & Experimental Allergy 2018-04-20

Abstract Background The world's most catastrophic and deadly thunderstorm asthma epidemic struck Melbourne, Australia, on November 21, 2016. Objective Among thunderstorm‐affected patients presenting to emergency rooms ( ER s), we investigated risk factors predicting severe attacks requiring admission hospital. Methods Thunderstorm‐affected were identified from records at the eight major Melbourne health services interviewed by telephone. Risk for hospital analyzed. Results We 1435/2248 (64%)...

10.1111/all.13609 article EN Allergy 2018-09-22

Abstract Background Sublingual immunotherapy (SLIT) for grass pollen allergy can modify the natural history of allergic rhinitis and is associated with increased allergen‐specific IgG 4 . competitively inhibits functional IgE on surface effector cells, such as mast cells basophils, from binding to allergens. To further understand important role memory B‐cell (Bmem) responses play in mediating beneficial effects SLIT, we assessed changes Bmem subsets induced by SLIT allergy. Methods Blood...

10.1111/all.15529 article EN cc-by-nc-nd Allergy 2022-09-25

Urinary leukotriene E4 (LTE4) concentrations were measured in six asthmatic subjects after treadmill exercise, and five allergen challenge. Exercise challenge produced a 42 ± 18% (mean SD) 22 8% fall FEV1, respectively. The baseline concentration of urinary LTE4 challenged with exercise was 64 (27 to 150) pg/mg creatinine (geometric mean 95% confidence interval), those it 36 (23 59) creatinine. did not change significantly the 24 h exercise. In contrast, there 4-fold increase during 3

10.1164/ajrccm/144.6.1411 article EN American Review of Respiratory Disease 1991-12-01

Background Recent epidemiological studies suggest that the adverse respiratory health effects caused by inhalation of fungal propagules are substantial. Knowledge prevalence and environmental determinants indoor levels is essential in designing effective avoidance measures. Aim To investigate fungi influence residential characteristics on within homes Melbourne, Australia. Methods Floor dust air samples were collected from bedrooms 485 houses over 1 year. The was analysed for ergosterol, a...

10.1046/j.1365-2222.1999.00640.x article EN Clinical & Experimental Allergy 1999-11-01

Australia has one of the highest prevalence rates internationally allergic conditions, such as asthma and eczema. Atopy is hallmark for development disease predisposes to inflammation in target organs. omega-3 (n-3) fatty acids (FAs) are thought act precursors formation less active inflammatory mediators, with potential reduce inflammation.

10.1111/j.1365-2222.2004.01852.x article EN Clinical & Experimental Allergy 2004-02-01
Coming Soon ...